Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

RTV

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 24 USDMF, 12 CEP/COS, 1 JDMF, 9 EU WC, 3 KDMF, 9 NDC API, 27 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

63 Drugs in Development

63 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers, 41 FDA Orange Book, 18 Europe, 7 Canada, 1 Australia, 25 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 100MG;25MG, TABLET;ORAL - 200MG;50MG, TABLET;ORAL - 100MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Rochem International Inc, 1 SPI Pharma, 10 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 2 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 17 BASF, 2 Bioplus Life Sciences, 1 Clariant, 12 Corel Pharma Chem, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 6 Ideal Cures Pvt Ltd, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Nanjing Bold Chemical, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 3 Roquette, 15 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Sigachi Industries, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

51 Coating Systems & Additives, 34 Solubilizers, 30 Fillers, Diluents & Binders, 24 Controlled & Modified Release, 22 Parenteral, 21 Film Formers & Plasticizers, 20 Topical, 17 Emulsifying Agents, 16 Thickeners and Stabilizers, 12 Taste Masking, 12 Direct Compression, 11 Lubricants & Glidants, 11 Granulation, 10 API Stability Enhancers, 9 Empty Capsules, 7 Surfactant & Foaming Agents, 5 Disintegrants & Superdisintegrants, 5 Rheology Modifiers, 4 Co-Processed Excipients, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Chewable & Orodispersible Aids

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 154 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 15 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

25 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

27 US Patents, 16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Arene Lifesciences	India	M/s Arene Life Sciences Private Limited	WC-0487	Ritonavir Ph. Eur	2023-12-26	2026-12-03	Plot No. 48-50, 209-211, IDA, Phase-ll, Pashamylaram, Patancheru, Sangareddy District-502307, Telangana State, India
04/06/2025	Aurobindo Pharma Limited	India	Apitoria Pharma Pvt Ltd	WC-0120	Ritonavir Ph. Eur	2022-07-15	2025-07-02	Survey No.:379, 385, 386, 388 to 396, Borpatla Village,Hathnoora Mandal, Sangareddy District ?502296, Telangana, India

RTV

RTV

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers

24 USDMF

12 CEP/COS

1 JDMF

9 EU WC

3 KDMF

9 NDC API

27 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

63 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers

41 FDA Orange Book

18 Europe

7 Canada

1 Australia

25 South Africa

15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 100MG;25MG

TABLET;ORAL - 200MG;50MG

TABLET;ORAL - 100MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Rochem International Inc

1 SPI Pharma

10 DKSH

1 PMC Isochem

1 Pharm-RX Chemical

2 Faran Shimi Pharmaceutical

6 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

4 ACG Worldwide

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

17 BASF

2 Bioplus Life Sciences

1 Clariant

12 Corel Pharma Chem

1 Finar

13 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

6 Ideal Cures Pvt Ltd

14 Kerry

3 Kima Chemical

6 Lonza Capsugel

4 Microlex e.U

2 Nanjing Bold Chemical

4 Novo Excipients

2 Pharmatrans-Sanaq

3 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

3 Roquette

15 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Sigachi Industries

1 Symrise

2 The Dow Chemical Company

1 Ulanqab Kema New Material

TABLET;ORAL - 12.5MG;75MG;50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons